We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.
Electrocatalytic oxygen evolution over supported small amorphous Ni-Fe nanoparticles in alkaline electrolyte.
The electrocatalytic oxygen evolution reaction (OER) is a critical anode reaction often coupled with electron or photoelectron CO2 reduction and H2 evolution reactions at the cathode for renewable energy conversion and storage. However, the sluggish OER kinetics and the utilization of precious metal catalysts are key obstacles in the broad deployment of these energy technologies. Herein, inexpensive supported 4 nm Ni-Fe nanoparticles (NiyFe1-yOx/C) featuring amorphous structures have been prepared via a solution-phase nanocapsule method for active and durable OER electrocatalysts in alkaline electrolyte. The Ni-Fe nanoparticle catalyst containing 31% Fe (Ni0.69Fe0.31Ox/C) shows the highest activity, exhibiting a 280 mV overpotential at 10 mA cm(-2) (equivalent to 10% efficiency of solar-to-fuel conversion) and a Tafel slope of 30 mV dec(-1) in 1.0 M KOH solution. The achieved OER activity outperforms NiOx/C and commercial Ir/C catalysts and is close to the highest performance of crystalline Ni-Fe thin films reported in the literature. In addition, a Faradaic efficiency of 97% measured on Ni0.69Fe0.31Ox/C suggests that carbon support corrosion and further oxidation of nanoparticle catalysts are negligible during the electrocatalytic OER tests. Ni0.69Fe0.31Ox/C further demonstrates high stability as there is no apparent OER activity loss (based on a chronoamperometry test) or particle aggregation (based on TEM image observation) after a 6 h anodization test. The high efficiency and durability make these supported amorphous Ni-Fe nanoparticles potentially applicable in the (photo)electrochemical cells for water splitting to make H2 fuel or CO2 reduction to produce usable fuels and chemicals.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app